They aren't talking about mAbs that are immunomodulators like lenz. They are talking about antiviral mAbs.
Every time a scientist/doctor talks about monoclonal antibodies in general they are talking about antiviral mAbs and never talking about immunological mAbs.
And they are right. Early on in a Covid infection is the most effective time for antivirals.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.